# Astarte Medical Partners

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/astarte-medical-partners

- Industry: Healthcare IT
- Headquarters: US
- Website: www.astartemedical.com
- Total disclosed funding: $13M
- Latest round: Series A (Sep 22, 2021)
- Investors on record: 10

## About

Astarte Medical Partners, Inc., based in the US, specializes in enhancing healthcare outcomes for children with medical complexity through innovative clinical intelligence platforms and tailored nutritional solutions.Founded in 2016, Astarte Medical Partners focuses on developing solutions for the neonatal intensive care unit (NICU) environment. The company was co-founded by industry experts Tammi Jantzen and Tracy Warren, with Tracy Warren currently serving as CEO. Astarte Medical has successfully completed 4 funding deals, with the most recent being a Series A funding round in September 2021, raising USD 7.6 mn from notable investors including Ben Franklin Technology Partners, Capita3, and Viking Global Investors.Astarte Medical offers innovative products and services centered around improving outcomes for children with medical complexity (CMC). Their core offering, SSS NICUtrition®, is a clinical intelligence platform that provides real-time actionable information to hospitals and NICU clinical teams, enabling them to standardize care protocols and optimize nutrition for preterm infants. This product addresses the unique needs of preterm infants, collaborating with healthcare providers, especially children's hospitals and NICUs, across the United States.Astarte Medical operates on a business model that integrates partnerships and direct sales to healthcare institutions. Revenue is generated through the deployment of their SSS NICUtrition® platform, involving subscription agreements with hospitals and healthcare networks. Clients, primarily pediatric healthcare providers, access the platform for a fee based on their service usage, ensuring tailored solutions for their specific needs.As of September 2021, Astarte Medical Partners plans to utilize the USD 7.6 mn raised in Series A funding to scale the sales of their NICUtrition® platform. The company intends to expand its presence in the NICU market by addressing critical needs such as malnutrition, suboptimal growth, and disparities in care. Astarte Medical is also exploring opportunities for new product launches aimed at further enhancing pediatric nutrition and care protocols.

## Funding rounds

- Series A, Sep 22, 2021, $7.6M — Ben Franklin Technology Partners, OCA Ventures, Viking Global Investors, Lunsford Capital, Capita3, Next Act Fund, Social Venture Circle of Philadelphia
- Series A, May 7, 2019, $5M — Ben Franklin Technology Partners, OCA Ventures, Viking Global Investors, Lunsford Capital, Wing, Keiretsu Capital, Next Act Fund, Keiretsu Forum Mid-Atlantic

## Investors

- Ben Franklin Technology Partners (https://capitalatlas.ai/funds/ben-franklin-technology-partners) — Series A
- OCA Ventures (https://capitalatlas.ai/funds/oca-ventures) — Series A
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series A
- Lunsford Capital — Series A
- Wing (https://capitalatlas.ai/funds/wing) — Series A
- Keiretsu Capital (https://capitalatlas.ai/funds/keiretsu-capital) — Series A
- Next Act Fund (https://capitalatlas.ai/funds/next-act-fund) — Series A
- Keiretsu Forum Mid-Atlantic — Series A
- Capita3 (https://capitalatlas.ai/funds/capita3) — Series A
- Social Venture Circle of Philadelphia — Series A